Predictive Value of MRI in Diagnosing Brain AVM Recurrence after Angiographically Documented Exclusion in Children

REFERENCES

1. 1.↵
   2. Stapf C,
   3. Mast H,
   4. Sciacca RR, et al

   . Predictors of hemorrhage in patients with untreated brain arteriovenous malformation. Neurology 2006;66:1350–55 doi:10.1212/01.wnl.0000210524.68507.87 pmid:16682666

   Abstract/FREE Full Text
2. 2.↵
   2. Rutledge WC,
   3. Ko NU,
   4. Lawton MT, et al

   . Hemorrhage rates and risk factors in the natural history course of brain arteriovenous malformations. Transl Stroke Res 2014;5:538–42 doi:10.1007/s12975-014-0351-0 pmid:24930128

   CrossRefPubMed
3. 3.↵
   2. van Beijnum J,
   3. van der Worp HB,
   4. Buis DR, et al

   . Treatment of brain arteriovenous malformations: a systematic review and meta-analysis. JAMA 2011;306:2011–19 doi:10.1001/jama.2011.1632 pmid:22068993

   CrossRefPubMedWeb of Science
4. 4.↵
   2. Blauwblomme T,
   3. Bourgeois M,
   4. Meyer P, et al

   . Long-term outcome of 106 consecutive pediatric ruptured brain arteriovenous malformations after combined treatment. Stroke 2014;45:1664–71 doi:10.1161/STROKEAHA.113.004292 pmid:24788975

   Abstract/FREE Full Text
5. 5.↵
   2. Beslow LA,
   3. Licht DJ,
   4. Smith SE, et al

   . Predictors of outcome in childhood intracerebral hemorrhage: a prospective consecutive cohort study. Stroke 2010;41:313–18 doi:10.1161/STROKEAHA.109.568071 pmid:20019325

   Abstract/FREE Full Text
6. 6.↵
   2. Gross BA,
   3. Du R

   . Natural history of cerebral arteriovenous malformations: a meta-analysis. J Neurosurg 2013;118:437–43 doi:10.3171/2012.10.JNS121280 pmid:23198804

   CrossRefPubMedWeb of Science
7. 7.↵
   2. Caplan JM,
   3. Yang W,
   4. Garzon-Muvdi T, et al

   . 120 rates of re-hemorrhage, risk factors, and outcomes of previously ruptured arteriovenous malformations (AVMs). Neurosurgery 2017;64(CN_suppl_1):226–26 doi:10.1093/neuros/nyx417.120

   CrossRef
8. 8.↵
   2. Mohr JP,
   3. Parides MK,
   4. Stapf C, et al

   ; international ARUBA investigators. Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial. Lancet 2014;383:614–21 doi:10.1016/S0140-6736(13)62302-8 pmid:24268105

   CrossRefPubMedWeb of Science
9. 9.↵
   2. Elhammady MS,
   3. Heros RC

   . Editorial: the ARUBA study—where do we go from here? J Neurosurg 2017;126:481–85 doi:10.3171/2015.7.JNS151408 pmid:27128587

   CrossRefPubMed
10. 10.↵
    2. Wong J,
    3. Slomovic A,
    4. Ibrahim G, et al

    . Microsurgery for ARUBA trial (A Randomized Trial of Unruptured Brain Arteriovenous Malformation)–eligible unruptured brain arteriovenous malformations. Stroke 2017;48:136–44 doi:10.1161/STROKEAHA.116.014660 pmid:27856955

    Abstract/FREE Full Text
11. 11.↵
    2. Mohr JP,
    3. Hartmann A,
    4. Kim H, et al

    . Viewpoints on the ARUBA trial. AJNR Am J Neuroradiol 2015;36:615–17 doi:10.3174/ajnr.A4204 pmid:25542877

    FREE Full Text
12. 12.↵
    2. Morgenstern PF,
    3. Hoffman CE,
    4. Kocharian G, et al

    . Postoperative imaging for detection of recurrent arteriovenous malformations in children. J Neurosurg Pediatr 2016;17:134–40 doi:10.3171/2015.6.PEDS14708 pmid:26517058

    CrossRefPubMed
13. 13.↵
    2. Javadpour M,
    3. Al-Mahfoudh R,
    4. Mitchell PS, et al

    . Outcome of microsurgical excision of unruptured brain arteriovenous malformations in ARUBA-eligible patients. Br J Neurosurg 2016;30:619–22 doi:10.1080/02688697.2016.1181153 pmid:27172987

    CrossRefPubMed
14. 14.↵
    2. Joyce C,
    3. Gomez CR

    . Reimagining ARUBA: theoretical optimization of the treatment of unruptured brain arteriovenous malformations. J Stroke Cerebrovasc Dis 2018;27:3100–07 doi:10.1016/j.jstrokecerebrovasdis.2018.07.007 pmid:30093202

    CrossRefPubMed
15. 15.↵
    2. Jimenez JE,
    3. Gersey ZC,
    4. Wagner J, et al

    . Role of follow-up imaging after resection of brain arteriovenous malformations in pediatric patients: a systematic review of the literature. J Neurosurg Pediatr 2017;19:149–56 doi:10.3171/2016.9.PEDS16235 pmid:27911246

    CrossRefPubMed
16. 16.↵
    2. Geibprasert S,
    3. Pongpech S,
    4. Jiarakongmun P, et al

    . Radiologic assessment of brain arteriovenous malformations: what clinicians need to know. Radiographics 2010;30:483–501 doi:10.1148/rg.302095728 pmid:20228330

    CrossRefPubMedWeb of Science
17. 17.↵
    2. Tranvinh E,
    3. Heit JJ,
    4. Hacein-Bey L, et al

    . Contemporary imaging of cerebral arteriovenous malformations. AJR Am J Roentgenol 2017;208:1320–30 doi:10.2214/AJR.16.17306 pmid:28267351

    CrossRefPubMed
18. 18.↵
    2. Lang SS,
    3. Beslow LA,
    4. Bailey RL, et al

    . Follow-up imaging to detect recurrence of surgically treated pediatric arteriovenous malformations. J Neurosurg Pediatr 2012;9:497–504 doi:10.3171/2012.1.PEDS11453 pmid:22546027

    CrossRefPubMed
19. 19.↵
    2. Gross BA,
    3. Frerichs KU,
    4. Du R

    . Sensitivity of CT angiography, T2-weighted MRI, and magnetic resonance angiography in detecting cerebral arteriovenous malformations and associated aneurysms. J Clin Neurosci 2012;19:1093–35 doi:10.1016/j.jocn.2011.11.021 pmid:22705129

    CrossRefPubMed
20. 20.↵
    2. Chowdhury AH,
    3. Ghose SK,
    4. Mohammad QD, et al

    . Digital subtraction angiography is superior to magnetic resonance angiography in diagnosis of cerebral arteriovenous malformation. Mymensingh Med J 2015;24:356–65 pmid:26007266

    PubMed
21. 21.↵
    2. Lee CC,
    3. Reardon MA,
    4. Ball BZ, et al

    . The predictive value of magnetic resonance imaging in evaluating intracranial arteriovenous malformation obliteration after stereotactic radiosurgery. J Neurosurg 2015;123:136–44 doi:10.3171/2014.10.JNS141565 pmid:25839923

    CrossRefPubMed
22. 22.↵
    2. Lescher S,
    3. Schniewindt S,
    4. Jurcoane A, et al

    . Time window for postoperative reactive enhancement after resection of brain tumors: less than 72 hours. Neurosurg Focus 2014;37:E3 doi:10.3171/2014.9.FOCUS14479 pmid:25434388

    CrossRefPubMed
23. 23.↵
    2. Bette S,
    3. Gempt J,
    4. Huber T, et al

    . Patterns and time dependence of unspecific enhancement in postoperative magnetic resonance imaging after glioblastoma resection. World Neurosurg 2016;90:440–47 doi:10.1016/j.wneu.2016.03.031 pmid:27001238

    CrossRefPubMed
24. 24.↵
    2. Gulani V,
    3. Calamante F,
    4. Shellock FG, et al

    . Gadolinium deposition in the brain: summary of evidence and recommendations. Lancet Neurol 2017;16:564–70 doi:10.1016/S1474-4422(17)30158-8 pmid:28653648

    CrossRefPubMed
25. 25.↵
    2. Semelka RC,
    3. Ramalho J,
    4. Vakharia A, et al

    . Gadolinium deposition disease: Initial description of a disease that has been around for a while. Magn Reson Imaging 2016;34:1383–90 doi:10.1016/j.mri.2016.07.016 pmid:27530966

    CrossRefPubMed
26. 26.↵
    2. Guo BJ,
    3. Yang ZL,
    4. Zhang LJ

    . Gadolinium deposition in brain: current scientific evidence and future perspectives. Front Mol Neurosci 2018;11:335 doi:10.3389/fnmol.2018.00335 pmid:30294259

    CrossRefPubMed
27. 27.↵
    2. Terashima KH,
    3. Reich DS

    . Gadolinium deposition: practical guidelines in the face of uncertainty. Lancet Neurol 2017;16:495–97 doi:10.1016/S1474-4422(17)30174-6 pmid:28653641

    CrossRefPubMed
28. 28.↵
    2. Aboukaïs R,
    3. Vinchon M,
    4. Quidet M, et al

    . Reappearance of arteriovenous malformations after complete resection of ruptured arteriovenous malformations: true recurrence or false-negative early postoperative imaging result? J Neurosurg 2017;126:1088–93 doi:10.3171/2016.3.JNS152846 pmid:27231973

    CrossRefPubMed
29. 29.↵
    2. Freudenstein D,
    3. Duffner F,
    4. Ernemann U, et al

    . Recurrence of a cerebral arteriovenous malformation after surgical excision. Cerebrovasc Dis 2001;11:59–64 doi:10.1159/000047612 pmid:11173795

    CrossRefPubMed
30. 30.↵
    2. Sorenson TJ,
    3. Brinjikji W,
    4. Bortolotti C, et al

    . Recurrent brain arteriovenous malformations (AVMs): a systematic review. World Neurosurg 2018;116:e856–66 doi:10.1016/j.wneu.2018.05.117 pmid:29807175

    CrossRefPubMed
31. 31.↵
    2. Muthusami P,
    3. Shkumat N,
    4. Rea V, et al

    . CT reconstruction and MRI fusion of 3D rotational angiography in the evaluation of pediatric cerebrovascular lesions. Neuroradiology 2017;59:625–33 doi:10.1007/s00234-017-1818-y pmid:28349170

    CrossRefPubMed
32. 32.↵
    2. Shkumat NA,
    3. Shroff MM,
    4. Muthusami P

    . Radiation dosimetry of 3D rotational neuroangiography and 2D-DSA in children. AJNR Am J Neuroradiol 2018;39:727–33 doi:10.3174/ajnr.A5568 pmid:29496725

    Abstract/FREE Full Text